CAUSEWAY THERAPEUTICS
A bio pharmaceutical spin out emerging from the University of Glasgow, working in the orthobiologic therapeutic space. Intellectual property has been generated via academic research demonstrating a proven mechanistic reasoning for the use of a microRNA therapy in the treatment of tendinopathies๏ปฟ.
CAUSEWAY THERAPEUTICS
Industry:
Biopharma Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
2015-01-01
Address:
Glasgow, Glasgow City, United Kingdom
Country:
United Kingdom
Website Url:
http://www.causewaytherapeutics.com
Total Employee:
11+
Status:
Active
Total Funding:
1000 K GBP
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API Google Analytics Apache ReCAPTCHA AJAX Libraries API DigiCert SSL Google Analytics Classic
Similar Organizations
Immutep
Immutep is a biopharmaceutical company developing immunotherapeutics in oncology.
Current Advisors List
Current Employees Featured
Founder
Investors List
Scottish Investment Bank
Scottish Investment Bank investment in Seed Round - Causeway Therapeutics
Mediqventures
Mediqventures investment in Seed Round - Causeway Therapeutics
Official Site Inspections
http://www.causewaytherapeutics.com
- Host name: paloma.hostns.io
- IP address: 109.70.148.65
- Location: London United Kingdom
- Latitude: 51.5164
- Longitude: -0.093
- Timezone: Europe/London
- Postal: EC2V
More informations about "Causeway Therapeutics"
Causeway Therapeutics
Our Pipeline Changing the treatment paradigm. As Causewayโs Tendinopathy program moves into clinical development, we continue to expand our pre-clinical programs focusing on age โฆSee details»
Causeway Therapeutics - Crunchbase Company Profile โฆ
Organization. Causeway Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. โฆSee details»
Our Story - Causeway Therapeutics
Profile Causeway Therapeutics is a clinical-stage Bio-pharmaceutical company that spun-out of the University of Glasgow in 2017 to develop novel microRNA therapies for the treatment of common musculoskeletal and age-related โฆSee details»
Causeway Therapeutics Company Profile | Management and
Causeway Therapeutics Profile and History. Causeway Therapeutics is a clinical-stage Bio-pharmaceutical company that spun-out of the University of Glasgow in 2017 to develop novel โฆSee details»
Causeway Therapeutics Ltd. - Drug pipelines, Patents, Clinical trials ...
Explore Causeway Therapeutics Ltd. with its drug pipeline, therapeutic area, technology platform, 2 clinical trials, Disease Domain:Nervous System Diseases, Technology Platform:miRNA, โฆSee details»
Causeway Therapeutics Company Profile 2024: โฆ
Causeway Therapeutics General Information Description. Developer of novel microRNA therapies designed to treat common musculoskeletal diseases. The company develops therapies that are based on identifying the molecular โฆSee details»
Causeway Therapeutics Overview | SignalHire Company Profile
Causeway Therapeutics is a private company that has been in the industry for 8 years. The company currently specializes in the Biotechnology, Biotechnology areas. The position of the โฆSee details»
Causeway Therapeutics - Leadership Team - The Org
The Leadership Team at Causeway Therapeutics oversees the strategic direction, financial management, medical initiatives, and commercial strategies of the company. Comprising the โฆSee details»
Causeway Therapeutics - Org Chart, Teams, Culture & Jobs - The Org
Causeway Therapeutics is a clinical-stage biopharmaceutical company specializing in musculoskeletal health. It develops novel microRNA therapies for the treatment of common โฆSee details»
CAUSEWAY THERAPEUTICS LIMITED overview - Find and update โฆ
Company Overview for CAUSEWAY THERAPEUTICS LIMITED (SC518335) Filing history for CAUSEWAY THERAPEUTICS LIMITED (SC518335) People for CAUSEWAY โฆSee details»
Causewaytherapeutics - CoBee Company Profile & Funding Rounds
Causewaytherapeutics. Causeway Therapeutics is a developer of therapies for tendon injuries and disorders. Business Model: Revenue: $0. Employees: 11-50. Rankings # 873 in โฆSee details»
Causeway Therapeutics - Overview, News & Similar companies
Causeway Therapeutics. Business Services · United Kingdom · <25 Employees. View Company Info for Free. About. Headquarters 11 The Square University Ave No, Glasgow, Unite...See details»
Board of Directors - Causeway Therapeutics
Prof. Declan Doogan Chairman Declan has over 30 years of industry experience in both major pharma and biotech. He was the Head of Worldwide Development at Pfizer, where many multi โฆSee details»
Causeway Therapeutics - Products, Competitors, Financials, โฆ
Causeway Therapeutics is a biotechnology company focused on developing miRNA therapeutics for age-related and fibrotic disorders. The company's main offerings include treatments for โฆSee details»
Causeway Therapeutics - Craft
Causeway Therapeutics is a company that focuses on the treatment of human and equine tendon disease. It has developed EquiMiR that mimics the natural microRNA while having improved โฆSee details»
Causeway Therapeutics Company Information - Funding, โฆ
Track over 23,965 companies. Discover Fast-growing Global startups. Seedtable uses technology and people to track over 23,965 companies to help you find the right ones to partner with.See details»
Our Team - Causeway Therapeutics
Leadership Causeway has assembled a formidable management team that have strong track records in drug development in companies ranging in size from start-up bio-techs through to โฆSee details»
CWT-001 - Drug Targets, Indications, Patents - Synapse - Patsnap
Nov 21, 2024 CWT-001: a Collagen modulators Drug, Initially developed by Causeway Therapeutics Ltd., Now, its global highest R&D status is Phase 2, Mechanism: Collagen โฆSee details»
Causeway Therapeutics - Facebook
Causeway Therapeutics is a clinical-stage Bio-pharmaceutical company that spun-out of the University of Glasgow in 2017 to develop novel microRNA therapies for the treatment of โฆSee details»
Pipeline - Causeway Therapeutics
As Causeway's Tendinopathy program moves into clinical development, we continue to expand our pre-clinical programs focusing on age-related indications that have the potential re-define โฆSee details»